influenza
season
global
strain
surveil
antivir
resist
reveal
sudden
emerg
oseltamivir
resist
influenza
isol
although
oseltamivir
resist
rate
vari
region
region
isol
test
global
found
oseltamivir
resist
histidin
tyrosin
mutat
residu
neuraminidas
gene
influenza
order
implement
effect
resist
test
local
novel
realtim
reversetranscriptas
pcr
rtpcr
assay
develop
detect
mutat
evalu
method
oseltamivir
resist
oseltamivir
sensit
influenza
isol
test
use
sanger
sequenc
refer
method
detect
resist
pyrosequenc
novel
rtpcr
assay
comparison
sanger
sequenc
sensit
specif
rtpcr
assay
respect
sensit
specif
pyrosequenc
respect
although
three
method
effect
detect
mutat
associ
oseltamivir
resist
rtpcr
assay
rapid
could
easili
incorpor
influenza
subtyp
protocol
elsevi
bv
right
reserv
begin
influenza
season
mark
signific
sudden
increas
resist
influenza
neuraminidas
na
inhibitor
oseltamivir
histidin
tyrosin
mutat
residu
na
gene
sheu
et
al
residu
gene
end
influenza
season
resist
rate
oseltamivir
global
countri
littl
previou
oseltamivir
resist
unit
state
canada
norway
report
resist
rate
respect
world
health
organ
earli
data
southern
hemispher
influenza
season
suggest
oseltamivir
resist
rate
among
isol
high
besselaar
et
al
addit
report
resist
season
isol
report
oseltamivir
resist
also
emerg
patient
infect
avian
influenza
de
jong
et
al
kimmbreschkin
et
al
le
et
al
bring
question
use
antivir
pandem
influenza
treatment
prophylaxi
moscona
world
health
organ
emerg
oseltamivir
resist
prompt
laboratorian
look
time
effect
mean
identifi
influenza
mutat
current
gold
standard
antivir
resist
screen
phenotyp
method
meijer
et
al
howev
genotyp
method
sanger
dideoxi
sequenc
analysi
na
gene
also
perform
detect
mutat
associ
strongli
oseltamivir
resist
phenotyp
sequenc
method
effect
detect
resist
labour
intens
long
turnaroundtim
quit
expens
suggest
need
rapid
highthroughput
approach
influenza
drug
resist
test
studi
introduc
util
novel
realtim
reversetranscriptas
pcr
rtpcr
assay
detect
histidin
tyrosin
mutat
residu
assay
design
produc
sigmoid
curv
isol
oseltamivir
suscept
curv
isol
oseltamivir
resist
thu
serv
quick
screen
tool
incorpor
influenza
subtyp
protocol
current
taqman
technolog
util
minor
groov
binder
mgb
form
stabl
complex
minor
groov
singlestrand
dna
increas
stabil
specif
afonina
et
al
uchiyama
et
al
due
qualiti
mgb
probe
aaatgcacccaat
reisdorf
et
al
character
shorter
length
higher
melt
temperatur
mgbbase
probe
therefor
highli
applic
detect
presenc
polymorph
sequenc
uchiyama
et
al
howev
increas
stabil
may
result
fals
posit
probe
cross
reactiv
therefor
one
reason
mgb
chemistri
gener
use
detect
point
mutat
avoid
incorrect
assign
point
mutat
effort
made
reduc
bind
oseltamivirresist
isol
point
mutat
design
mgb
probe
detect
wildtyp
sequenc
limit
cross
reactiv
similar
sequenc
mgb
probe
design
mgb
link
mutabl
base
pair
accomplish
design
probe
mutat
bp
probe
site
mgb
linkag
studi
compar
util
rtpcr
assay
sanger
sequenc
current
refer
method
detect
well
pyrosequenc
emerg
method
detect
point
mutat
duw
schweiger
specimen
use
studi
popul
moder
resist
oseltamivir
resist
rate
ontario
isol
one
hundr
one
patient
isol
use
studi
influenza
posit
isol
similar
genet
lineag
collect
influenza
season
ontario
canada
upon
arriv
laboratori
neuraminidas
detect
specimen
use
quantitect
probe
rtpcr
kit
qiagen
publish
primer
probe
schweiger
et
al
tabl
use
realtim
pcr
thermocycl
stratagen
subtyp
assay
valid
previous
sensit
specif
method
detect
clinic
specimen
schweiger
et
al
also
use
extens
extern
qualiti
assur
panel
classic
phenotyp
assay
mutat
residu
gene
detect
use
sanger
dideoxi
sequenc
forti
specimen
wildtyp
histidin
residu
specimen
tyrosin
residu
chosen
randomli
analysi
patient
specimen
grown
rmk
cell
nucleic
acid
extract
viral
cultur
isol
use
nuclisen
easymag
tm
system
accord
manufactur
instruct
rna
extract
l
eagl
minimum
essenti
media
emem
biowhittak
elut
volum
l
control
extract
specimen
test
human
target
gapdh
use
gapdh
taqman
control
reagent
appli
biosystem
perform
sanger
sequenc
revers
transcript
amplif
gene
perform
use
onestep
rtpcr
kit
qiagen
three
l
rna
combin
l
onestep
rtpcr
buffer
l
dntp
l
onestep
rtpcr
enzym
mix
l
u
rnase
inhibitor
l
primer
forward
takao
et
al
revers
yuen
et
al
final
concentr
tabl
l
water
revers
transcript
amplif
perform
use
icycl
biorad
convent
pcr
thermocycl
follow
condit
cycl
c
min
cycl
c
min
follow
cycl
amplif
c
c
c
min
final
extens
cycl
c
min
follow
visual
pcr
product
use
gel
electrophoresi
label
pcr
product
perform
use
big
dye
termin
cycl
sequenc
kit
appli
biosystem
one
l
dna
combin
l
bigdy
l
bigdy
buffer
l
forward
primer
l
water
icycl
biorad
util
label
use
cycl
c
min
cycl
c
c
c
min
label
pcr
product
purifi
use
dyeex
column
kit
qiagen
accord
manufactur
instruct
nucleotid
sequenc
determin
use
genet
analyz
appli
biosystem
analyz
use
finchtv
geospiza
chroma
technelysium
dna
sequenc
softwar
pyrosequenc
revers
transcript
amplif
na
gene
extract
rna
influenza
isol
perform
use
onestep
rtpcr
kit
qiagen
three
l
rna
combin
l
onestep
rtpcr
buffer
l
dntp
l
onestep
rtpcr
enzym
mix
l
u
rnase
inhibitor
l
primer
naforward
narevers
reisdorf
et
al
final
concentr
tabl
revers
transcript
amplif
perform
use
icycl
biorad
convent
pcr
thermocycl
follow
condit
cycl
c
min
c
c
min
c
min
c
min
follow
cycl
amplif
c
c
c
min
one
extens
cycl
c
min
visual
agaros
gel
l
pcr
product
combin
l
bind
mix
compos
l
bind
buffer
biotag
l
water
l
streptavidinsepharos
hp
bead
amersham
bioscienc
sampl
shaken
use
plate
shaker
labnet
rpm
min
room
temperatur
combin
l
anneal
mix
compos
l
anneal
buffer
biotag
l
sequenc
primer
naforward
sequenc
tabl
pyrosequenc
carri
use
pyromark
tm
id
biotag
accord
manufactur
instruct
design
novel
rtpcr
assay
refer
sequenc
align
use
clustal
w
larkin
et
al
primer
probe
design
eye
use
consensu
sequenc
assay
design
evalu
use
primer
express
appli
biosystem
order
test
secondari
structur
sequenc
primer
probe
assay
list
tabl
rtpcr
carri
use
l
rna
combin
l
quantitect
probe
rtpcr
master
mix
l
quantitect
rt
mix
l
primer
probe
l
water
revers
transcript
rtpcr
carri
stratagen
use
cycl
c
min
cycl
c
min
cycl
c
c
min
ensur
probe
failur
due
mutat
residu
sampl
degrad
inhibit
subtyp
rtpcr
run
parallel
plate
determin
limit
detect
lod
control
rtpcr
assay
serial
tenfold
dilut
nucleic
acid
oseltamivirsensit
clinic
influenza
isol
test
start
concentr
viru
assay
tcid
ml
dilut
seri
test
method
triplic
determin
reproduc
well
singl
simul
clinic
test
lod
assay
determin
probit
regress
confid
interv
use
spss
version
assess
crossreact
rtpcr
assay
nontarget
respiratori
pathogen
panel
nucleic
acid
respiratori
pathogen
test
use
assay
nucleic
acid
use
panel
deriv
either
clinic
specimen
atcc
strain
extract
inhibit
control
clinic
specimen
perform
upon
initi
specimen
test
use
seeplex
rv
detect
kit
seegen
drew
et
al
roh
et
al
lod
rtpcr
assay
control
assay
determin
use
serial
tenfold
dilut
nucleic
acid
sequenceconfirm
oseltamivirsensit
clinic
influenza
solomon
island
specimen
fig
b
lod
calcul
use
probit
regress
confid
interv
found
tcid
ml
assay
tcid
ml
control
assay
interassay
intraassay
variabl
experi
fig
determin
lod
assay
nucleic
acid
extract
influenza
oseltamivirsensit
isol
use
determin
lod
assay
start
concentr
viru
amplif
curv
b
shown
determin
oseltamivir
resist
influenza
isol
use
rtpcr
assay
repres
amplif
curv
shown
oseltamivir
suscept
resist
clinic
isol
isol
oseltamivir
suscept
produc
sigmoid
curv
green
oseltamivirresist
isol
produc
curv
blue
approxim
resist
isol
test
produc
lowfluoresc
nonsigmoid
curv
red
ment
indic
assay
reproduc
intraassay
coeffici
variat
cv
found
higher
assay
assay
interassay
cv
found
higher
assay
assay
cross
reactiv
rtpcr
assay
assess
use
panel
nucleic
acid
respiratori
pathogen
viral
nucleic
acid
deriv
clinic
specimen
bacteri
nucleic
acid
extract
clinic
specimen
atcc
strain
obtain
oseltamivirsensit
influenza
nucleic
acid
use
posit
control
specif
probe
publish
previous
schweiger
et
al
repeat
studi
sensit
specif
rtpcr
assay
evalu
use
influenza
isol
includ
isol
test
previous
mutat
use
sanger
sequenc
refer
method
pyrosequenc
isol
collect
ontario
patient
influenza
season
similar
genet
lineag
sensit
specif
rtpcr
assay
found
respect
tabl
compar
favour
sensit
specif
pyrosequenc
respect
contrast
isol
approxim
isol
produc
cycl
threshold
ct
valu
approxim
produc
nonsigmoid
low
fluoresc
amplif
curv
test
use
rtpcr
assay
fig
interpret
curv
problemat
differ
amplif
curv
oseltamivirsensit
isol
nonsigmoid
flat
curv
subset
resist
isol
appar
tat
rtpcr
assay
hr
nucleic
acid
extract
studi
initi
influenza
season
first
season
signific
oseltamivir
resist
observ
global
influenza
strain
residu
sheu
et
al
world
health
organ
result
sudden
increas
global
resist
drug
felt
addit
nation
global
surveil
program
oseltamivir
resist
detect
protocol
implement
ontario
clinic
laboratori
assess
resist
local
studi
evalu
use
novel
rtpcr
assay
detect
isol
comparison
sanger
sequenc
pyrosequenc
found
three
method
may
role
influenza
diagnost
test
rtpcr
assay
rapid
effect
test
detect
oseltamivir
resist
mutat
residu
sanger
sequenc
establish
method
detect
point
mutat
therefor
use
refer
method
studi
although
accur
determin
mutat
residu
quit
expens
timeeffici
sequenc
everi
isol
moder
resist
popul
like
ontario
isol
oseltamivir
resist
addit
time
restrict
sequenc
align
analys
sangersequenc
isol
must
done
use
separ
program
gener
requir
expertis
oper
compar
sanger
sequenc
pyrosequenc
also
quit
effect
determin
mutat
sensit
specif
respect
pyrosequenc
less
time
consum
provid
unambigu
sequenc
primer
bind
site
contrast
sanger
sequenc
provid
sequenc
first
bp
sequenc
pourmand
et
al
unlik
sanger
sequenc
instrument
biotag
pyrosequenc
builtin
align
capabl
make
sequenc
analysi
less
difficult
studi
pyrosequenc
found
highli
sensit
success
pyrosequenc
depend
sequenc
analyz
sinc
homopolymer
sequenc
repetit
nucleotid
three
time
alway
discern
parameswaran
et
al
sanger
sequenc
pyrosequenc
hamper
need
pcr
amplifi
na
gene
everi
isol
sequenc
lengthen
turnaroundtim
tat
oseltamivirresist
test
add
extra
step
influenza
test
algorithm
rtpcr
assay
found
sensit
specif
sanger
sequenc
decreas
tat
tat
rtpcr
assay
h
nucleic
acid
extract
compar
h
sanger
sequenc
h
pyrosequenc
design
mgb
probe
detect
wild
type
mutant
sequenc
allow
confirmatori
sequenc
minor
resist
isol
oppos
major
wild
type
isol
would
time
cost
effici
implement
rtpcr
assay
influenza
season
would
reduc
time
cost
isol
sequenc
sinc
isol
produc
sigmoid
curv
would
sequenc
use
sanger
pyrosequenc
technolog
confirm
presenc
mutat
although
assay
valid
use
viru
cultur
cell
carri
separ
influenza
subtyp
assay
also
perform
success
use
nucleic
acid
extract
directli
specimen
assay
therefor
incorpor
easili
current
subtyp
protocol
thu
decreas
tat
even
addit
detect
oseltamivir
resist
season
influenza
rtpcr
assay
also
util
pandem
influenza
outbreak
sinc
thought
oseltamivir
resist
alreadi
report
avian
influenza
strain
de
jong
et
al
kimmbreschkin
et
al
le
et
al
signific
impact
influenza
pandem
occur
lipsitch
et
al
current
oseltamivir
recommend
treatment
prophylaxi
avian
influenza
schunemann
et
al
stockpil
countri
rtpcr
assay
serv
screen
tool
resist
could
perform
rapidli
enough
affect
treatment
decis
short
tat
highthroughput
natur
assay
help
conserv
resourc
pandem
global
emerg
oseltamivir
resist
influenza
specimen
result
recent
develop
sever
molecular
method
resist
detect
addit
sanger
sequenc
pyrosequenc
exampl
allelicdiscrimin
snp
assay
detect
mutat
publish
carr
et
al
novel
rtpcr
assay
report
compar
favour
carr
assay
exhibit
parallel
test
characterist
cross
reactiv
similar
tat
howev
sinc
rtpcr
assay
requir
one
probe
snp
assay
natur
util
two
probe
rtpcr
assay
lower
cost
per
test
multiplex
easili
influenza
detect
algorithm
realtim
pcr
base
drawback
rtpcr
assay
oseltamivir
resist
confer
mutat
residu
detect
addit
compensatori
mutat
gene
hemagglutinin
gene
abe
et
al
conserv
gene
would
recogn
use
method
howev
sinc
oseltamivir
resist
mediat
current
mutat
global
emerg
resist
mani
jurisdict
world
health
organ
rapid
cost
effici
screen
target
method
highthroughput
resist
test
clinic
specimen
conclus
emerg
mediat
oseltamivir
resist
global
influenza
isol
indic
need
rapid
molecular
test
detect
mutat
rapid
screen
approach
present
studi
may
allow
highthroughput
test
oseltamivir
resist
time
fashion
abil
incorpor
method
realtim
pcrbase
influenza
detect
test
algorithm
potenti
assay
use
influenza
pandem
make
test
valuabl
tool
use
clinic
microbiolog
laboratori
